June 25, 2003
Bristol-Myers Squibb Has Recalled
The Food and Drug Administration (FDA) has released the following
Cholestyramine for Oral Suspension, USP Powder, 4 grams cholestyramine
resin, USP, per packet, 60 single dose packets, Apothecon. Recall # D-259-3.
Lot no. 1A32512 Exp. Date 2/29/2004.
Recalling Firm: Bristol-Myers Squibb Company, New Brunswick, NJ, by letters
on April 11, 2003.
Manufacturing Firm: Bristol-Myers Squibb Company, Prinston, NJ. Firm
initiated recall is ongoing.
Superpotent (6 month stability).
VOLUME OF PRODUCT IN COMMERCE
2,011 ctns/60 packets ea.